$MRK News Article - KEYTRUDA (pembrolizumab) Plus
Post# of 151
(Total Views: 167)
Posted On: 10/20/2023 2:10:47 PM
$MRK News Article - KEYTRUDA (pembrolizumab) Plus Trastuzumab and Chemotherapy Significantly Improved Progression-Free Survival (PFS) Versus Trastuzumab and Chemotherapy in First-Line HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma https://marketwirenews.com/news-releases/keyt...32925.html
(0)
(0)Merck & Co. Inc. (MRK) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼